Bien-Etre Labs Achieves Seven Million Dollars ($7M) Investment Funding

HIGH POINT, N.C.--()--Bien-Etre Labs, (www.bienetre.com) a nutraceutical research, discovery and development company focusing on pre- and probiotic products to regulate the human biome, as well as researching, designing and developing novel approaches to healthy aging and longevity, has completed a $7 Million investment funding round. The investment will help Bien-Etre Labs aggressively accelerate product development and manufacturing toward meeting its mission to provide solutions where traditional medical approaches have fallen far short, for example, in the fields of metabolic disorders, digestive health, allergies, skin health, IBS, and strengthening the immune system.

The financing builds on an exceptional 2019 and first-and second-quarter 2020 performance for Bien-Etre Labs which saw promising discoveries and development of natural approaches to enhance the shelf life of probiotic products and sourcing natural proprietary technology with properties unique to the brand, strategizing manufacturing options and kick-starting sales and marketing. Also, as previously reported, Bien-Etre Labs recently appointed Steve Prescott as its President, who brings exemplary pharma business and marketing experience. https://www.businesswire.com/news/home/20200624005850/en/Bien-Etre-Labs-Global-Headquarters-High-Point-North

Prescott adds that “Bien-Etre Labs’’ offering is well-timed with the rapidly increasing demand for natural health solutions, particularly immune system defense products. Bien-Etre Labs is well positioned to corner the nutraceutical market by harnessing the power of the human biome with new and re-envisioned technologies and is finding corollary health approaches using the earth’s biome. It is very exciting to see the Company’s successes occur before our eyes”.

About Bien-Etre Labs, LLC: Bien-Etre Labs was founded by Dr. Mjalli in 2014 and is incorporated in Delaware and North Carolina, where it operates one of its labs in High Point. Dr. Adnan Mjalli (www.migusa.com) has patented hundreds of pharmaceuticals and formulations beneficial to the human condition. A focus of the Bien-Etre Labs product line is to promote healthy aging and longevity by introducing 100% natural, proprietary products to repair imbalances in the human biome, where Mjalli believes, through his 30 years of research and drug development, “lies one of the most important opportunities to naturally enhance the body’s ability to protect itself from life threatening diseases.”

Contacts

Steve Prescott, President
Bien-Etre Labs, LLC
Email:
sprescott@bienetrelabs.com
Website:
www.bienetrelabs.com

Contacts

Steve Prescott, President
Bien-Etre Labs, LLC
Email:
sprescott@bienetrelabs.com
Website:
www.bienetrelabs.com